Dermatology 13th edition. London: Elsevier. P 453-463 2. Schmidt W, Groves R. Immunobullous Diseases. In: Rook’s Textbook of Dermatology: 9 th edition. Griffith CE, Barker J, Bleiker T, et al., ed. 2016. United Kingdom: Wiley Publishing. P 50.1-50.9. 3. Payne AS, Stanley JR. Vesicobullous disorders: Pemphigus. In: Fitzpatrick Dermatology 9 th edition. Kang S, Amagai M, Bruckner A.L et al. ed. 2019. New York: McGraw Hill, p 909-933 4. Beigi PKM. A Clinician’s Guide to Pemphigus Vulgaris.2018. Switzerland: Springer Publishing. P29-33 5. Van dder Wier, Jonkman MF, Horvath B, et al. in: Barbara Horvath ed. Autoimmune Bullous Disease Text and Review. 2nd edition. Switzerland: Springer Publishing P65-76 6. Aberer, F.; Hochfellner, D.A.; Sourij, H.; Mader, J.K. A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital. J. Clin. Med. 2021, 10, 2154. https://doi.org/10.3390/ jcm10102154 7. Hone NL, Mutasim DF. Pemphigus vulgaris successfully treated with doxycycline monotherapy. 2016 vol 97, e25-e27 8. Carty MM, Fivenson D. Two decades of using the combination of tetracycline derivatives and niacinamide as steroid-sparing agents in the management of pemphigus: defining a niche for these low-toxicity agents. J Am Acad Dermatol http://dx.doi.org/10.1016/j.jaad.2014.04.040. 9. Damayanti N, Sumarno. Glucocorticoid tapering: a literature review. J Islamic Pharm 2020: 5(2) 1-4. 10. Chaffins ML, Collison D, Fivenson D, et al. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases. J Am Acad Dermatol 1993;28:998- 1000 11. Calebotta A, Saenz A,M, Gonzalez F. Pemphigus vulgaris:benefits of tetracycline as adjuvant therapy in a series of thirteen patients. Int J Dermatol 1998;38:217-221. 12. Joly P, Horvath B, Patsatsi A. 2020. Updated S2K guidelimes on the management of pemphigus vulgaris and foliaceus initiated by the European academy of dermatology and venereology (EADV). JEADV 2020: 34: 1900-1913
Advances in Veterinary Dermatology, Volume 7: Proceedings of the Seventh World Congress of Veterinary Dermatology, Vancouver, Canada, July 24 - 28, 2012